Tredaptive

New Zealand - English - Medsafe (Medicines Safety Authority)

Buy It Now

Active ingredient:
Laropiprant 20 mg;  ; Nicotinic acid 1000 mg
Available from:
Merck Sharp & Dohme (New Zealand) Limited
INN (International Name):
Laropiprant 20 mg
Pharmaceutical form:
Tablet
Composition:
Active: Laropiprant 20 mg   Nicotinic acid 1000 mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hyprolose Hypromellose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Sodium stearyl fumarate
Units in package:
Blister pack, Al/Al - 7 tablets, 7 tablets
Class:
Prescription
Prescription type:
Prescription
Manufactured by:
F.I.S. Fabbrica Italiana Sintetici SpA
Product summary:
Package - Contents - Shelf Life: Blister pack, Al/Al - 7 tablets - 7 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 14 tablets - 14 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 28 tablets - 28 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 56 tablets - 56 tablets - 24 months from date of manufacture stored at or below 30°C
Authorization number:
TT50-8008
Authorization date:
2007-08-29

Similar products

Search alerts related to this product

Share this information